371 related articles for article (PubMed ID: 28843624)
1. Sorafenib stimulates human skin type mast cell degranulation and maturation.
Mizukami Y; Sugawara K; Kira Y; Tsuruta D
J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin.
Metz M; Botchkarev VA; Botchkareva NV; Welker P; Tobin DJ; Knop J; Maurer M; Paus R
Exp Dermatol; 2004 May; 13(5):273-81. PubMed ID: 15140017
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme.
Ito N; Sugawara K; Bodó E; Takigawa M; van Beek N; Ito T; Paus R
J Invest Dermatol; 2010 Apr; 130(4):995-1004. PubMed ID: 20043013
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
[TBL] [Abstract][Full Text] [Related]
5. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib induced eruptive melanocytic lesions.
Uhlenhake EE; Watson AC; Aronson P
Dermatol Online J; 2013 May; 19(5):18184. PubMed ID: 24011281
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
[TBL] [Abstract][Full Text] [Related]
8. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
9. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
10. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
Wygrecka M; Dahal BK; Kosanovic D; Petersen F; Taborski B; von Gerlach S; Didiasova M; Zakrzewicz D; Preissner KT; Schermuly RT; Markart P
Am J Pathol; 2013 Jun; 182(6):2094-108. PubMed ID: 23562441
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
Sui X; Krantz SB; Zhao ZJ
Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Shichiri H; Yamamoto K; Tokura M; Ishida T; Uda A; Bito T; Nishigori C; Nakagawa T; Hirano T; Yano I; Hirai M
Biochem Biophys Res Commun; 2017 Apr; 485(2):227-233. PubMed ID: 28237700
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE
J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781
[TBL] [Abstract][Full Text] [Related]
17. Stress and Nasal Allergy: Corticotropin-Releasing Hormone Stimulates Mast Cell Degranulation and Proliferation in Human Nasal Mucosa.
Yamanaka-Takaichi M; Mizukami Y; Sugawara K; Sunami K; Teranishi Y; Kira Y; Paus R; Tsuruta D
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803422
[TBL] [Abstract][Full Text] [Related]
18. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
[TBL] [Abstract][Full Text] [Related]
19. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
